GALECTO BIOTECH ApS: Financial statements 2024
CVR: 34878366
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2024. In 2024, the company reported a gross profit of EUR 5,477,168 and a net result of EUR 310,297 compared with EUR 849,392 the year before. That is a decrease of 64.1% compared with the year before. Equity in the 2024 report amounted to EUR 8,553,704. The solvency ratio was 95.9%. The company had 36 employees in the financial year.
- Gross Profit
- EUR 5,477,168
- Profit/Loss
- EUR 310,297
- Equity
- EUR 8,553,704
- Total Assets
- EUR 8,920,077
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 5.5 mio. EUR | 310 t. EUR | 8.6 mio. EUR | 36 |
| 2023 | - | 15.3 mio. EUR | 849 t. EUR | 8.2 mio. EUR | 29 |
| 2022 | - | 12.3 mio. EUR | 819 t. EUR | 7.4 mio. EUR | 36 |
| 2021 | - | 9.4 mio. EUR | 765 t. EUR | 3.7 mio. EUR | 29 |
| 2020 | - | 4.9 mio. EUR | 214 t. EUR | 2.9 mio. EUR | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 31, 2024, Jonathan Paul Freve has left the board of directors of GALECTO BIOTECH ApS.
GALECTO BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK 15,256,504, and the net result was DKK 849,392.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees (2018). In 2025, the company reported a gross profit of EUR 1,039,275 and a net result of EUR -709,079 compared with EUR 310,297 the year before. Equity in the 2025 report amounted to EUR 7,844,625.